Immunomedics (IMMU)

Add to Watchlists Create an Alert
3.36 +0.08  +2.44%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Immunomedics Cash from Operations Quarterly:

-3.994M for Dec. 31, 2012
View Full Chart

Immunomedics Cash from Operations Quarterly Chart

    Immunomedics Historical Cash from Operations Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -3.994M
    Sept. 30, 2012 -7.339M
    June 30, 2012 -6.179M
    March 31, 2012 21.21M
    Dec. 31, 2011 -4.423M
    Sept. 30, 2011 -6.054M
    June 30, 2011 3.344M
    March 31, 2011 -6.336M
    Dec. 31, 2010 -1.800M
    Sept. 30, 2010 -7.105M
    June 30, 2010 0.4243M
    March 31, 2010 0.8328M
    Dec. 31, 2009 -1.202M
    Sept. 30, 2009 -7.123M
    June 30, 2009 -4.310M
    March 31, 2009 -4.635M
    Dec. 31, 2008 -3.701M
    Sept. 30, 2008 33.99M
    June 30, 2008 -6.286M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Cash From Operations

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

    Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
    Learn More

    Get data for

    IMMU Cash from Operations Quarterly Benchmarks

    Companies
    Seattle Genetics 50.80M
    AVEO Pharmaceuticals -21.61M
    Threshold Pharmaceuticals 33.48M

    IMMU Cash from Operations Quarterly Rankings

    Overall 47th percentile
    3962 of 7600
    Sector 37th percentile
    406 of 653 in Healthcare
    Industry 57th percentile
    102 of 238 in Biotechnology

    IMMU Cash from Operations Quarterly Range, Past 5 Years

    Minimum -7.339M Sep 2012
    Maximum 33.99M Sep 2008
    Average -0.5625M